Composition, useful to treat or prevent viral infection, comprises a hexanucleotide as biological component and optionally a carrier, where the hexanucleotide arranged in specific direction against a protein-like biopolymer

摘要

Composition (I), comprises at least a hexanucleotide as a biologically effective component and optionally at least a carrier where the hexanucleotide is arranged in specific direction against a protein-like biopolymer. Independent claims are included for: (1) a procedure for the preparation of hexanucleotide specifically directed against protein-like biopolymer comprises: providing a first system, which comprises n different sequence hexanucleotide, where each hexanucleotide contains one or more hexanucleotide with same nucleotide sequence, each of the other different nucleotide sequence of the hexanucleotide differs and entire number of n is 2-4096; providing a second system, which comprises at least the protein-like biopolymer; and contacting the first system with the second system under conditions, which enables a goal specific hexanucleotide at the protein-like biopolymer, under development of a hexanucleotide/biopolymer complex; and (2) a kit comprising a hexanucleotide to reduce or completely inhibit the biological activity of the protein-like biopolymers. ACTIVITY : Virucide; Anti-HIV. MECHANISM OF ACTION : None given.